Contact Us
Student ServicesLocation: Building 517, Room 111
Phone: (909) 607-0389
Fax: (909) 607-8086
Email: student_services[at symbol]kgi.edu
2012 Commencement Speaker
Keck Graduate Institute is pleased to announce that Tina S. Nova, PhD will be the featured speaker at commencement activities on May 12, 2012.
Dr. Nova has served as the President and Co-founder of Genoptix, Inc., a Novartis company, since its inception. Genoptix is focused on developing and commercializing evidence-based diagnostic tests to improve physician's ability to optimize patient outcomes. Prior to Genoptix, Dr. Nova was a co-founder of Nanogen, Inc., a provider of molecular diagnostic tests, where she served as its Chief Operating Officer and President from 1994 to 2000.
Dr. Nova served as Chief Operating Officer of Selective Genetics, a targeted therapy, biotechnology company, from 1992 to 1994, and was in various director-level positions with Ligand Pharmaceuticals Incorporated, a drug discovery and development company, from 1988 to 1992. Dr. Nova also held various research and management positions with Hybritech, Inc., a former subsidiary of Eli Lilly & Company, a pharmaceutical company. She also serves on the board of directors of Arena Pharmaceuticals, Inc., and Adamis Pharmaceuticals Corporation. Dr. Nova is a former Chair of the board of directors of BIOCOM, a life science association representing approximately 500 member companies; an Ernst & Young Entrepreneur of the Year recipient; an Athena Pinnacle Award Winner; she also received the Tullis-Dickerson & Co., CEO of the Year award, and was a founding board member of the California Institute for Regenerative Medicine for stem cell research.
Dr. Nova holds a B.S. in Biological Sciences from the University of California, Irvine where she graduated with honors, and a Ph.D. in Biochemistry from the University of California, Riverside.